An observational study in Postoperative Ileus, Postoperative Nausea and Postoperative Complications, sponsored by Eric Schwenk. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-06.
Sponsored by Eric Schwenk · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 108 studies in Postoperative Nausea and Vomiting with a site in United States — 7 open to participants now, 10 under way, none of them phase 3. Postoperative Nausea and Vomiting · United States.
Among the 108 studies in Postoperative Nausea and Vomiting with a site in United States, this one is one of 4 that started in 2021, is one of 8 observational ones, and was the 87th registered.
638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.
Browse Postoperative Nausea and Vomiting studies →7 of the 108 studies in Postoperative Nausea and Vomiting with a site in United States are open now. Recruiting first, the newest first:
Columbia University · Sites in United States
Ages 12–21
Endeavor Health · Sites in United States
Ages 18–90
University of Pennsylvania · Sites in United States
Ages 18–75
United States Naval Medical Center, Portsmouth · Sites in United States
Ages 18–79 · Women only · Healthy volunteers
Jyoti Pandya · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 65 Postoperative Nausea and Vomiting studies recruiting now, 22 (34%) set no upper age limit and 37 (57%) stop at 75 or younger; 14 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
108 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 18 · Phase 3 14 · Phase 4 27
First in 2002; this study’s year is marked. 4 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 22 is below the median of 208 across 93 observational studies indexed under Postoperative Nausea and Vomiting.
Median enrollment 115 across the 100 interventional studies, 1,104 across the 8 observational. Of the 87 that completed or were terminated, 51 (59%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 108 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Eric Schwenk as lead sponsor.
Eric Schwenk has 1 study filed under Postoperative Nausea and Vomiting — fewer than ten, so there is no comparison to draw.
8 of the studies in Postoperative Nausea and Vomiting with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07152249Vanderbilt University Medical CenterAdvancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial | 2026-12 |
| NCT06488001United States Naval Medical Center, PortsmouthPreoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery | 2026-12 |
| NCT05805423University of California, DavisENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery | 2026-12-31 |
| NCT07099222University of ArizonaEfficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks | 2026-12-31 |
| NCT07639723Endeavor HealthAprepitant to Improve Same Day Discharge for TKA | 2027-07 |
Add all 8 to your calendar (.ics) → With an account.
Among the 108 studies in Postoperative Nausea and Vomiting with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Point-of-care gastric ultrasound will be used to measure stomach contents postoperative in patients who underwent colorectal surgery. Stomach volume and status (empty or full) will be compared retrospectively to the standard clinical criteria for diet advancement to determine if stomach volume via ultrasound is associated with successful diet advancement, nausea/vomiting, nasogastric tube replacement, length of stay, and other clinical outcomes. Clinicians performing clinical care will be blinded to the ultrasound exam results.
Patient population: Patients undergoing colorectal surgery will be enrolled prospectively (both cancer and non-cancer patients).
Inclusion Criteria:
Exclusion Criteria:
Patients with previous gastric surgery
Research Design/Protocol: We will perform postoperative point-of-care ultrasound examinations in colorectal surgery patients and will record gastric volumes at set time points, including preoperative and the morning of postoperative day 1. The surgical team, who will be blinded to the results of the ultrasound exam, will make decisions to advance diet, remove nasogastric tube, and begin oral medications based on standard clinical criteria. At the completion of the study we will determine if there is any association between gastric volume on ultrasound and patient complications, such as nausea/vomiting, replacement of nasogastric tube, aspiration of gastric contents, inability to tolerate solid diet, prolonged admission/length of stay, and other clinical outcomes.
Outcomes: Our exploratory outcome measures will be tolerance of diet, replacement of NG tube, nausea/vomiting, time to flatus, aspiration pneumonia/pneumonitis, and length of stay.
Adult patients scheduled for colorectal surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with previous gastric surgery
This patient population will include postoperative patients who received a gastrointestinal surgery and are being assessed with the bedside gastric ultrasound.
Diagnostic Test: Bedside gastric ultrasound
Bedside ultrasound exam of the stomach
Tolerance of diet advancement
Includes replacement of NGT, downgrading diet
Time frame: 0 - 14 days
Emesis
Time frame: 0 - 14 days
Time to first flatus
Time frame: 0 - 14 days
Aspiration pneumonitis
Clinical or radiographic evidence of aspiration
Time frame: 0 - 14 days
Time to first bowel movement
Time frame: 0 - 14 days
Nausea
Time frame: 0 - 14 days
Plan to share: No
Ran from Feb 2021 to primary completion in Jun 2021, 3 months.
Of 52 non-industry observational studies under Postoperative Nausea and Vomiting, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 37. This study's 3 months is below that.
Counting every sponsor, half of 52 studies reached it within 11 months; a quarter within 4 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Postoperative Nausea and Vomiting →